The company expands to add process-development and clinical-manufacturing capabilities at its large-scale bulk biologics facility.
Apr 12, 2013
By:
Patricia Van Arnum
The company expands to add process-development and clinical-manufacturing capabilities at its large-scale bulk biologics facility.
|
Company is notified of GMP violations at facility in Catania, Italy.
Apr 11, 2013
By:
Patricia Van Arnum
Company is notified of GMP violations at facility in Catania, Italy.
|
Maryland is the latest state to consider whether to include additional requirements for substitution of biological products.
Apr 11, 2013
By:
Patricia Van Arnum
Maryland is the latest state to consider whether to include additional requirements for substitution of biological products.
|
Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013
By:
Patricia Van Arnum
Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
|
Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013
By:
Patricia Van Arnum
Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
|
Apr 2, 2013
By:
Patricia Van Arnum
Novartis loses an appeal in seeking patent protection in India for its anticancer drug.
|
CROs are keeping pace with the increased globalization of the biopharmaceutical/pharmaceutical industry.
Mar 2, 2013
By:
Patricia Van Arnum
CROs are keeping pace with the increased globalization of the biopharmaceutical/pharmaceutical industry.
|
As biopharmaceutical/pharmaceutical companies increase their development of biologic-based drugs, companies providing analytical instrumentation and laboratory testing goods and services are, in turn, offering improved tools for biologic characterization, biomanufacturing, and related testing.
Mar 1, 2013
By:
Patricia Van Arnum
As biopharmaceutical/pharmaceutical companies increase their development of biologic-based drugs, companies providing analytical instrumentation and laboratory testing goods and services are, in turn, offering improved tools for biologic characterization, biomanufacturing, and related testing.
|
Applying QbD and PAT facilitates process understanding in lyophilization.
Mar 1, 2013
By:
Patricia Van Arnum
Applying quality-by-design and process analytical technology facilitates process understanding and control of various operations in lyophilization.
|
|
